Fundraising Fox

NEA Secondary

Timonium

Fox Verdict
Sign up to see your fit

Fund manager profile

NEA Secondary is a venture fund manager based in Timonium. SEC filings show 1 venture fund on record, most recently NEA Secondary Opportunity Fund, L.P. ($468.2M offering) filed July 2024.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Timonium, US

What they invest in

from 6 of 0 portfolio companies

Biotech ×4Healthtech ×2

HQs:United States×17

Board seats · per SEC filings · 17

what is this? ⓘ
Senti Biosciences Holdings, Inc.SEC filing

$40M raise · filed Jun 2026 · via Edward Mathers

Nexo Therapeutics, Inc.SEC filing

$60M raise · filed Mar 2026 · via Ali Behbahani

Affinia Therapeutics Inc.SEC filing

$45M raise · filed Oct 2025 · via Edward Mathers

SpyGlassPharma, Inc.SEC filing

$75M raise · filed Jun 2025 · via Ali Behbahani

Tune Therapeutics, Inc.SEC filing

$208M raise · filed Jan 2025 · via Ali Behbahani

OnKure Therapeutics, Inc.SEC filing

$65M raise · filed Oct 2024 · via Edward T. Mathers

Brenig Therapeutics, Inc.SEC filing

$65M raise · filed Jul 2024 · via Edward Mathers

Cardurion Pharmaceuticals, Inc.SEC filing

$260.4M raise · filed Jul 2024 · via Edward Mathers

858 Therapeutics, Inc.SEC filing

$50.4M raise · filed Jul 2024 · via Ali Behbahani

Waymark, Inc. / DESEC filing

$22M raise · filed Nov 2023 · via Mohamad Makhzoumi

Arcellx, Inc.SEC filing

$100M raise · filed Feb 2023 · via Ali Behbahani

Launchpad Therapeutics, Inc.SEC filing

$30M raise · filed Dec 2022 · via Ali Behbahani

FirstLight Bio, Inc.SEC filing

$25.4M raise · filed Apr 2022 · via Ali Behbahani

Sorriso Pharmaceuticals, Inc.SEC filing

$31.4M raise · filed Jan 2022 · via Edward Mathers

CardionomicSEC filing

$11.5M raise · filed Oct 2021 · via Ali Behbahani

Mirum Pharmaceuticals, Inc.SEC filing

$10M raise · filed Dec 2020 · via Edward T. Mathers

Genocea BiosciencesSEC filing

$79.9M raise · filed Aug 2020 · via Ali Behbahani

Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

Where is NEA Secondary located?
NEA Secondary is headquartered in Timonium, US.